T-Cypher Bio
Description: T-Cypher Bio develops TCR-based therapeutics for solid tumors & autoimmune diseases using its D-Cypher platform to overcome target identification challenges.
Country: UK
Based in: Oxford
Founded: 2020
Funding Stage: Seed
Tags: ['Biotechnology', 'D-Cypher', 'Autoimmune']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
